Hamad, Jimer A.
HRN: 21-75-40 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
12/19/2022
CEFTRIAXONE 1G (VIAL)
12/19/2022
12/25/2022
IV
800mg
Q24h
PCAP C
Waiting Final Action
12/19/2022
CEFTAZIDIME 1GM (VIAL)
12/19/2022
12/26/2022
IVT
350 Mg
8 Hrs
PCAP D
Waiting Final Action
12/21/2022
OXACILLIN 500MG (VIAL)
12/21/2022
12/27/2022
IV
200
Q6
PCAP D
Waiting Final Action